QWO

Radiology Software For Referral Of Findings Related To Fibrotic Lung Disease.

Product code
QWO
Device name
Radiology Software For Referral Of Findings Related To Fibrotic Lung Disease.
Device class
Class 2
21 CFR
21 CFR 892.2085
Medical specialty
Radiology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
4
Summaries archived here
3 (direct download)
510(k) clearances (all years, FDA)
4 (all years; only the last 3 years are listed here)

FDA classification definition

Radiology software for referral of findings related to fibrotic lung disease is a prescription image processing device that analyzes computed tomography images to suggest the presence of disease or of an imaging finding suggestive of disease. The output of this device is intended to be used as adjunctive information as part of a referral pathway in the overall diagnostic assessment process.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (4)

Last three years. Most recent: 2025-11-07.

NumberDecision dateApplicantDevice nameSummary
K2520412025-11-07Imvaria, Inc.Fibresolve (with PCCP)PDF
K2418912025-01-10Imvaria, Inc.ScreenDxPDF
K2424672024-12-19Imbio, Inc.IQ-UIPPDF
DEN2200402024-01-12Imvaria, Inc.Fibresolve

3 summaries are archived here for direct download.

Official FDA classification page: QWO
Classification and pathway per current FDA publications. Data from openFDA (CC0).